Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bloomsbury Genetic Therapies Ltd.
Headquarters: London, United Kingdom
Website: https://bloomsburygtx.com/
Year Founded: 2021
Status: Private
BioCentury | Oct 24, 2024
Product Development
Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals
Therapies aim to enhance lysosomal function to clear cholesterol and glycosphingolipids, mostly via small molecules
BioCentury | Oct 12, 2022
Finance
Oct. 11 Quick Takes: Large syndicate backs Neumora in $112M round
Plus Lilly, Nimbus in deal for AMPK activators, and updates from PureTech-Nektar, Albireo, Merck and more
Items per page:
1 - 2 of 2